LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs

By Czuczwar S.J.   Swiader M.   Kuzniar H.   Gasior M.   Kleinrok Z.  

European Journal of Pharmacology, Vol. 359, Iss. 2, 1998-10 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite

Influence of agents affecting voltage-dependent calcium channels and dantrolene on the anticonvulsant action of the AMPA/kainate receptor antagonist LY 300164 in mice

By Swiader M.   Borowicz K.K.   Porebiak J.   Kleinrok Z.   Czuczwar S.J.  

European Neuropsychopharmacology, Vol. 12, Iss. 4, 2002-08 ,pp. : 311-319

Elsevier

Access to resources Recommend Favorite

The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics

By Borowicz K.K.   Gasior M.   Kleinrok Z.   Czuczwar S.J.  

European Journal of Pharmacology, Vol. 281, Iss. 3, 1995-08 ,pp. : 319-326

Elsevier

Access to resources Recommend Favorite

NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice

By De Sarro G.   Siniscalchi A.   Ferreri G.   Gallelli L.   De Sarro A.  

European Journal of Pharmacology, Vol. 408, Iss. 1, 2000-11 ,pp. : 25-34

Elsevier

Access to resources Recommend Favorite

Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 10, 2018-03 ,pp. : 1099-1110

Bentham Science Publishers

Access to resources Recommend Favorite